TriLyte
Is a New Crohn's Disease Treatment on the Horizon? »
"Oct. 17, 2012 -- A drug used to treat psoriasis may provide a much-needed option for people with bad cases of Crohn's disease.
In the new study, some people with moderate to severe Crohn's given Stelara (ustekinumab) began to see imp"...
Read the Is a New Crohn's Disease Treatment on the Horizon? article »
TriLyte
TriLyte® with flavor packs
(PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral
solution)
When reconstituted with water to a volume of 4 liters, this solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, bicarbonate 17 mmol/L and potassium 5 mmol/L.
This package contains the following ingredients:
Polyethylene Glycol 3350
420 g
Sodium Bicarbonate
5.72 g
Sodium Chloride
11.2 g
Potassium Chloride
1.48 g
Store in sealed container at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F).
DRUG DESCRIPTION
TriLyte (peg-3350, sodium chloride, sodium bicarbonate and potassium chloride) ® is a white powder for reconstitution containing 420 g polyethylene glycol 3350, 5.72 g sodium bicarbonate, 11.2 g sodium chloride, 1.48 g potassium chloride. Flavor packs, each containing 3.22 g of flavoring ingredients, are attached to the 4 liter bottle. See individual flavor packs for complete listing of ingredients. When dissolved in water to a volume of 4 liters, TriLyte (peg-3350, sodium chloride, sodium bicarbonate and potassium chloride) ® with flavor packs (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution) is an isosmotic solution, for oral administration, having a pleasant mineral water taste. One flavor pack can be added before reconstitution to flavor the solution. TriLyte® with flavor packs (peg-3350, sodium chloride, sodium bicarbonate and potassium chloride) is administered orally or via nasogastric tube as a gastrointestinal lavage.
Last reviewed on RxList: 3/24/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional TriLyte Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
GI Disorders
Get the latest treatment options.






